Mast cells are critical effector cells of allergic inflammation, releasing mediators that are preformed (e.g., histamine, serine proteases, and proteoglycans) or newly synthesized (e.g., eicosanoids and cytokines) in response to diverse stimuli including stem-cell factor (SCF) and immunoglobulin (Ig) E and antigen-dependent activation (1) . Mast cells are heterogeneous with respect to their histochemical staining characteristics, granule content, and pattern of eicosanoid generation, their phenotype depending on the local tissue microenvironment. Thus, serosal and connective tissue mast cells counterstain with safranin after alcian blue staining whereas mucosal mast cells do not. Mouse mast-cell protease phenotype is influenced by cytokines (2) (3) (4) (5) and the local tissue microenvironment (6) and demonstrates remarkable plasticity during the course of Trichinella spiralis intestinal infestation (7, 8) . With respect to eicosanoid generation, rat and mouse serosal mast cells generate prostaglandin (PG) D 2 in preference to leukotriene (LT) C 4 (9) , whereas mast cells isolated from the intestine of T. spiralisinfested rats generate LTC 4 in preference to PGD 2 (10) . Eicosanoid generation by other populations of rodent mast cells has not been studied due to difficulties in obtaining these cells in sufficient numbers or purity.
Bone marrow-derived mast cells (BMMC) from BALB/c mice, developed in WEHI-3 cell-conditioned medium as a source of interleukin (IL)-3 for 3 to 4 wk (11, 12) , represent a relatively immature population of committed mastcell progenitors that reconstitute both connective tissue and mucosal mast cells in mast cell-deficient mice of the WBB6F1/J-W/W v strain (13) . BMMC fail to stain with safranin after alcian blue staining, synthesize chondroitin sulfate E proteoglycan, are poor in histamine content, and preferentially produce LTC 4 over PGD 2 when activated by perturbation of the high-affinity Fc receptor for IgE (Fc RI) (14) or the receptor tyrosine kinase c-kit (15) . In prior studies we have shown that culture of BMMC for 2 to 7 d in SCF led to priming for increased PGD 2 synthesis, an effect that was augmented by IL-3, IL-9, or IL-10 (16). In contrast, culture of bone-marrow cells for 4 wk in SCF and IL-10 derived a population of BMMC with poorly developed eicosanoid biosynthetic pathways. Subsequent addition of IL-3 to the culture for 1 to 2 wk elicited a population of mast cells with markedly upregulated IgE-dependent LTC 4 generation (17) .
In the present study we have evaluated the effect of tissue matrix and basement membrane proteins on mouse mastcell eicosanoid generation using Matrigel, an extract from the Engelbreth-Holm-Swarm mouse sarcoma that is rich in basement-membrane proteins. These proteins include laminin, type IV collagen, heparan sulfate proteoglycans, entactin, nidogen (18) , and, to a lesser extent, fibronectin (19) . In addition to these structural proteins, Matrigel is embedded with a variety of growth factors and cytokines that include transforming growth factor (TGF)-␤ 1, fibroblast growth factor, tissue plasminogen activator, platelet-derived growth factor, and other poorly characterized factors (20) . We demonstrate that BMMC developed in the presence of Matrigel have increased granularity, counterstain with safranin, and have increased IgE-dependent eicosanoid biosynthesis compared with conventional BMMC derived in the absence of Matrigel. Increased IgE-dependent eicosanoid biosynthesis was also seen in conventional BMMC cultured on Matrigel for 5 d, an effect that was reproduced by TGF-␤ 1 and inhibited by a neutralizing antibody to TGF-␤ 1.
Materials and Methods

Materials
Matrigel, growth factor-reduced Matrigel, laminin, fibronectin, and type IV collagen were supplied by Collaborative Biomedical Products, Becton Dickinson Labware, Bedford, MA. Chicken IgY anti-TGF-␤ 1 and isotype-matched control chicken IgY were supplied by Genzyme, Cambridge, MA. Rabbit antiserum to human cytosolic phospholipase (cPL) A 2 , which cross-reacts with mouse cPLA 2 (16) , was a gift from Dr. J. D. Clark, Genetics Institute, Cambridge, MA; rabbit antisera to 5-lipoxygenase (5-LO) and to 5-LO activating protein (FLAP) were gifts from Dr. J. F. Evans, Merck and Co., West Point, PA; and rabbit antiserum to cyclooxygenase (COX) 1 was a gift from Dr. W. L. Smith, Michigan State University, East Lansing, MI.
Culture of BMMC in the Presence of Matrigel
Bone-marrow cells from male BALB/c mice (Jackson Laboratories, Bar Harbor, ME) were cultured at a cell density of 5 ϫ 10 5 cells/ml for 3 to 4 wk in 50% enriched medium (RPMI 1640 containing 100 U/ml of penicillin, 100 g/ml streptomycin, 10 g/ml gentamicin, 2 mM L -glutamine, 0.1 mM nonessential amino acids, and 10% fetal calf serum) and 50% WEHI-3 cell (American Type Culture Collection, Rockville, MD)-conditioned medium as a source of IL-3 in 25-cm 2 flasks (Corning Laboratories, Corning, NY) in the presence of Matrigel. Flasks were coated with Matrigel at 4 Њ C using precooled flasks and pipette tips. Approximately 2.5 ml of Matrigel was added to each 25-cm 2 flask. After 1 and 2 wk of culture, cells were treated for 1 h at 37 Њ C with Dispase, a bacillus-derived neutral metallo protease (Collaborative Biosystems, Cambridge, MA), which digested the Matrigel and allowed the isolation of cells adherent to or embedded in the matrix as well as nonadherent cells. Adherent and nonadherent cells were passed together at 5 ϫ 10 5 cells/ml up to 3 wk. After 3 wk of culture, nonadherent and adherent cells were cultured separately. At 4 wk of culture, both populations of cells gave rise to nonadherent and adherent cells that were studied separately.
Culture of Conventional BMMC
Bone-marrow cells from male BALB/c mice were cultured at a cell density of 5 ϫ 10 5 cells/ml for 3 to 4 wk in 50% enriched medium and 50% WEHI-3 cell-conditioned medium (12) in 25-cm 2 flasks. To determine the effects of connective tissue matrix or its individual components on histochemical staining and IgE-dependent eicosanoid generation, conventional BMMC were cultured on plates coated with Matrigel or growth factor-reduced Matrigel for 5 to 20 d; were cultured on plates coated with 2.5 to 25 g/cm 2 of laminin, fibronectin, or type IV collagen for 5 d; or were cultured in the presence of 0.1 to 10 ng/ml purified human TGF-␤ 1 for 5 d. In selected experiments, 1 to 1,000 ng/ml chicken IgY anti-TGF-␤ 1 or isotype-matched control chicken IgY was added to the cultures.
Histochemical Staining of Cells
At each passage, 10 4 cells were applied to glass slides by cytocentrifugation. The slides were air-dried for 10 min and stained with alcian blue and safranin or were fixed in Mota's fixative and stained with toluidine blue (21) . The alcian blue/safranin-stained cells were categorized on the basis of the proportion of granules that were positive for alcian blue or safranin. Cells were scored into one of the following groups: ( 1 ) containing only alcian bluepositive granules, ( 2 ) containing more alcian blue-positive than safranin-positive granules, ( 3 ) containing approximately equal numbers of alcian blue-positive and safranin-positive granules, ( 4 ) containing more safranin-positive than alcian blue-positive granules, and ( 5 ) containing only safranin-positive granules (21) .
Fc RI-Dependent Activation
Cells were sensitized with 8 g/ml monoclonal IgE anti-trinitrophenyl (TNP) at a cell density of 10 7 cells/ml in BMMC culture medium at 37 Њ C for 30 min, washed, resuspended at 5 ϫ 10 6 cells/ml in Tyrode's buffer containing 1.8 mM Ca , 0.1% gelatin, and 10 mM N -2-hydroxyethylpiperazine-N Ј -ethane sulfonic acid (pH 7.2), and activated with 50 ng/ml TNP-conjugated bovine serum albumin (TNP-BSA) at 37 Њ C for 10 min to elicit an immediate phase of eicosanoid generation and secretory granule exocytosis (15) .
Measurement of Eicosanoids
The release of PGD 2 into the supernatant was measured by radioimmunoassay (Amersham Corp., Arlington Heights, IL). Supernatants were assayed for LT generation by reverse phase-high-performance liquid chromatography (RP-HPLC) (22) . Samples were applied to a 5-m 4.6 ϫ 250-mm C18 Ultrasphere RP-HPLC column (Beckman, Fullerton, CA) equilibrated with a solvent of methanol/acetonitrile/water/acetic acid (10:15:80:0.2, vol/vol), pH 5.6. The column was eluted at a flow rate of 1 ml/min with a programmed concave gradient (System Gold curve 6) to 55% of the equilibrating solvent and 45% methanol over 2.5 min. Beginning at 5 min, the proportion of methanol was increased linearly to 75% over the next 15 min and was maintained at this level for 10 min more. Online ultraviolet absorbance was monitored at 270 and 280 nm. LTs were quantified by calculating the ratio of the area corresponding to the LT peak and the area of the PGB 2 internal standard peak with correction for the molar extinction coefficient of each lipid. LT data are expressed in pmol/10 6 cells. LTA 4 generation was assessed by summing its conversion products LTC 4 , LTB 4 , and 6-trans LTB 4 diastereoisomers (6-t-LTB 4 ).
Measurement of Secretory Granule Exocytosis
The cell pellets were suspended in enriched medium and disrupted by freeze-thawing. ␤ -hexosaminidase, a marker of mast-cell secretory granule exocytosis, was quantitated in the supernatants and pellets by spectrophotometric analysis of the hydrolysis of p -nitrophenyl-␤ -D -2-acetamido-2-deoxyglucopyranoside. The percent release of ␤ -hexosaminidase was calculated by the formula (S/[S ϩ P]) ϫ 100, where S and P are the ␤ -hexosaminidase contents of equal portions of each supernatant and cell pellet, respectively (15) .
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis Immunoblotting
Expression of cPLA 2 , 5-LO, FLAP, and COX-1 in lysates of BMMC was evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) immunoblotting as previously described (16, 17) .
Statistics
All experiments were conducted at least four times. Statistical significance was analyzed by performing Student's paired or unpaired t tests, as appropriate. Statistical significance was considered for P Ͻ 0.05 (23) .
Results
Derivation of Mast Cells in the Presence of Matrigel
When BALB/c bone-marrow cells were cultured in the presence of WEHI-3 cell-conditioned medium (as a source of IL-3) and Matrigel, both nonadherent cells (present in the tissue culture medium) and adherent cells (embedded in the Matrigel and/or adherent to the tissue culture flask) were obtained. These two populations were passed together until the third week of culture, at which point they were cultured separately. At 1 wk after culturing the two populations separately, each population gave rise to both nonadherent and adherent cells. The nonadherent cells were identical in histochemical staining and eicosanoid generation regardless of adherent or nonadherent origin. Likewise, the adherent cells were identical in histochemical staining regardless of origin (data not shown). Thus, data were pooled to allow for two populations (namely, nonadherent and adherent) regardless of origin.
Histochemical Characterization of BMMC Derived in the Presence of Matrigel
Although nonadherent mast cells derived in the presence of Matrigel did not acquire metachromasia more rapidly than conventional BMMC (Table 1) , and mast cells adherent to the Matrigel were contaminated by a population of nonmetachromatic cells, both populations of mast cells contained denser granules on toluidine blue staining compared with conventional BMMC, suggesting a greater degree of morphologic maturity (Figure 1) . Further, the nonadherent and adherent populations of BMMC derived in the presence of Matrigel revealed more intense counterstaining with safranin when compared with conventional BMMC (Table 1 and Figure 1 ). Thus 78 and 75%, respectively, of the nonadherent and adherent BMMC derived in the presence of Matrigel that stained with alcian blue contained some safranin-positive granules at 3 wk of culture, compared with 35% of conventional BMMC ( n ϭ 4, P Ͻ 0.005) ( Table 1 ). The same pattern was seen at 4 wk.
Fc RI-Dependent Eicosanoid Generation by BMMC Derived in the Presence of Matrigel
The generation of nonadherent cells from an adherent population, and the reciprocal generation of adherent cells from a nonadherent population, suggest that these cells cycled between an adherent and nonadherent state. Because the adherent population of mast cells derived in the presence of Matrigel did not exhibit greater than 50% metachromasia due to contamination with nonmetachromatic macrophagelike cells, because adherent cells needed proteolytic pretreatment for matrix detachment before IgE-dependent activation for eicosanoid generation, and because the conventional BMMC are nonadherent cells, only the nonadherent cells were studied for eicosanoid generation.
After 4 to 6 wk of culture, BMMC derived in the presence of Matrigel generated 6-fold more PGD 2 and ‫ف‬ 30-fold more total LTs in response to activation through Fc RI than did conventional BMMC (Figures 2A-2D ). LTC 4 was the principal LT product of conventional BMMC and was increased 11-fold in BMMC derived in the pres- ence of Matrigel. BMMC derived in the presence of Matrigel also exhibited significant generation of 6-t-LTB 4 and LTB 4 , which were barely detectable in conventional BMMC (Figure 2) . Secretory granule exocytosis, assessed by release of ␤-hexosaminidase activity, was not significantly different between BMMC derived in the presence of Matrigel and conventional BMMC ( Figure 2E ).
Culture of Conventional BMMC on Matrigel
To further investigate the components of Matrigel responsible for upregulation of arachidonic acid metabolism, a simpler culture system was sought. BMMC were derived in the absence of Matrigel for 4 wk, when they were Ͼ 95% toluidine blue-positive, and were then cultured in the presence or absence of Matrigel. Although PG and LT generation were upregulated less dramatically after 5 d of culture on Matrigel compared with BMMC derived in the presence of Matrigel, this was mostly due to variability in the generation of eicosanoids from conventional BMMC. Total LT and PGD 2 generation were comparable between BMMC derived in the presence of Matrigel (Figure 2 ) and conventional BMMC cultured on Matrigel for 5 d (Figure 3) . This, therefore, provided an experimental approach to the analysis of which of the basement membrane component(s) that are present in Matrigel contributed to priming for increased eicosanoid generation. Initial experiments focused on whether matrix proteins and/or growth factors associated with those matrix proteins were responsible. Hence, conventional BMMC were cultured for 5 d in the presence or absence of Matrigel or a growth factor-reduced Matrigel and then activated through FcRI. BMMC treated with Matrigel or growth factor-reduced Matrigel generated approximately equal quantities of PGD 2 and total LT products that were increased ‫ف‬ 2-and ‫ف‬ 2.5-fold, respectively, compared with conventional BMMC maintained in the absence of Matrigel ( Figures 3A and 3B ). BMMC treated with both Matrigel and growth factor-reduced Matrigel generated approximately 1.6-fold more LTC 4 per million cells compared with untreated cells, and generated significant amounts of 6-t-LTB 4 and LTB 4 , whereas these products were barely detectable in untreated cells ( Figure 3A) . In contrast, secretory granule exocytosis, measured by the release of ␤-hexosaminidase, was approximately equal for all three sets of BMMC ( Figure 3C ).
TGF-␤1 Upregulates Eicosanoid Generation in BMMC
To examine the contribution of individual matrix components to the upregulation of eicosanoid generation, BMMC were cultured in flasks coated with laminin, type IV collagen, or fibronectin at 2.5, 10, or 25 g/cm 2 for 5 d. Although Matrigel elicited an upregulation in FcRI-dependent LT and PG generation, as previously seen, none of these extracellular matrix components induced an upregulation in FcRI-dependent eicosanoid generation when compared with untreated cells (data not shown).
Growth factor-reduced Matrigel still contains physiologic concentrations of TGF-␤1 (1.7 ng/ml; manufacturer's specification sheet). We therefore investigated whether TGF-␤1 was contributing to the upregulation of IgE-dependent eicosanoid generation elicited by Matrigel. BMMC derived without Matrigel were treated with or without Matrigel for 5 d, or with 0.01 to 10 ng/ml TGF-␤1. A dosedependent upregulation in FcRI-dependent LT generation was observed in response to priming with TGF-␤1. Maximal LT generation was observed in BMMC treated with 1.0 ng/ml TGF-␤1, those cells generating approximately the same amount of LTs as did Matrigel-treated cells (Figures 4A-4D) . A dose-dependent increase in PGD 2 generation was also observed although this was not statistically significant ( Figure 4E ). The modest increase in secretory granule exocytosis observed in response to TGF-␤1 was not statistically significant ( Figure 4F ).
Anti-TGF-␤1 Neutralizing Antibody Inhibits the Upregulation of Eicosanoid Generation Elicited by Matrigel
To confirm that matrix-associated TGF-␤1 was responsible for the increase in eicosanoid generation observed in Matrigel-treated BMMC, we evaluated the effect of a neutralizing antibody to TGF-␤1. BMMC derived in the absence of Matrigel were treated with 1.0 ng/ml TGF-␤1 and various concentrations of a chicken anti-TGF-␤1-specific neutralizing IgY antibody or an isotype-matched control antibody. The anti-TGF-␤1 antibody, but not the control IgY, acted in a dose-dependent manner to inhibit the upregulation in FcRI-dependent LT generation elicited by 1 ng/ml TGF-␤1; maximal inhibition was observed with 100 to 1,000 ng/ml anti-TGF-␤1 (data not shown). Incorporation of 1,000 ng/ml anti-TGF-␤1 in the Matrigel matrix inhibited the priming of BMMC by Matrigel for increased LT and PG generation to approximately the same levels as cells cultured in the absence of Matrigel, whereas the isotype-matched antibody was without effect (Figures 5A-5E ). The neutralizing antibody had no effect on secretory granule exocytosis ( Figure 5F ).
Upregulation of cPLA 2 by Matrix-Associated TGF-␤1
Culture of BMMC in the presence of Matrigel therefore elicited an increase in IgE-dependent generation of LTC 4 , LTB 4 , 6-t-LTB 4 (the nonenzymatic product of LTA 4 ), and PGD 2 that was abrogated by a neutralizing antibody to TGF-␤1 ( Figure 5 ). These data suggested that the site of upregulation of eicosanoid biosynthesis was in the supply of arachidonic acid to downstream enzymes. Several species of PLA 2 that liberate free arachidonic acid from cell-membrane phospholipids have been described in BMMC, including the low molecular-weight group IIA and group V enzymes (24, 25) and 85-kD cPLA 2 (16) . Gene disruption experiments indicate that cPLA 2 is essential for eicosanoid generation in BMMC (26) . We therefore evaluated the effect of Matrigel in the presence or absence of neutralizing antibodies on expression of cPLA 2 , 5-LO, FLAP, and COX-1 in BMMC. Culture of conventional BMMC on Matrigel for 5 d led to an increase in expression of cPLA 2 but not of 5-LO, FLAP, or COX-1 (Figure 6) . The increase in expression of cPLA 2 in response to Matrigel was reduced to basal levels in a dose-dependent manner by the anti-TGF-␤1 antibody, which was without effect on the expression of FLAP (Figure 7) .
Discussion
Mast cells are critical effector cells of inflammation whose phenotype is determined by the local tissue microenvironment (6-8). Although the protease phenotype of murine mast cells can be assessed on a cell-by-cell basis using immunohistochemical techniques (6) (7) (8) , the pattern of eicosanoid generation is not amenable to such exquisite phenotyping. Thus, LT and PG generation has been assessed in bulk preparations of partially purified tissue mast cells and in immature progenitor BMMC exposed to certain cytokines. Our previous studies have demonstrated that SCF favors the development of the COX-1/PGD 2 synthase pathway for PGD 2 generation (16) whereas IL-3 is critical for the development of the 5-LO/LTC 4 synthase pathway of LTC 4 generation (17) .
The present study extends these studies of the microenvironmental regulation of eicosanoid generation in mouse mast cells to evaluate the effect of connective tissue matrix and basement membrane components on eicosanoid generation by BMMC. When bone-marrow cells were cultured for 3 to 4 wk in WEHI-3 cell-conditioned medium, as a source of IL-3, in the presence of Matrigel, a population of mast cells was derived with enhanced maturity and a shift toward a connective-tissue mast-cell phenotype ( Figure 1 and Table 1 ). BMMC derived in SCF, with (17) or without IL-10 (2), also exhibited an increase in safranin staining, which in the latter case was accompanied by an increase in histamine content and heparin proteoglycan biosynthesis (2) . The individual component(s) in Matrigel responsible for the increased density of granules and counterstaining with safranin were not determined due to the complexity of the Matrigel culture system.
Eicosanoid biosynthesis was markedly upregulated in BMMC derived in the presence of Matrigel compared with conventional BMMC (Figure 2) . Indeed, the Matrigel protocol provided enough substrate to overwhelm the terminal enzymes of LT biosynthesis, leading to substantial generation of 6-t-LTB 4 , nonenzymatic degradation products of LTA 4 that are not typically generated in significant quantity by conventional BMMC (27) (Figures 2A-2C) . To further elucidate the component(s) of the basement membrane responsible for the upregulation in FcRIdependent eicosanoid products, we developed a less complicated culture system in which conventional BMMC were cultured with Matrigel for 5 d. This elicited upregulation of both PGD 2 and LT generation to levels similar to those seen from BMMC developed over 4 wk in the presence of Matrigel (Figures 3 and 5) . Culture of BMMC for 5 d with individual matrix proteins present within Matrigel demonstrated that laminin, type IV collagen, and fibronectin were not responsible for upregulated eicosanoid biosynthesis. Nevertheless, culture of BMMC on either Matrigel or growth factor-reduced Matrigel for 5 d primed for an upregulation of FcRI-dependent eicosanoid generation ( Figures 3A and 3B) . Although the concentrations of epidermal growth factor, insulin-like growth factor 1, and platelet-derived growth factor are reduced in growth factor-reduced Matrigel, TGF-␤1 is present at physiologic concentrations. Indeed, the capacity of Matrigel to prime BMMC for increased eicosanoid biosynthesis was reproduced by 1 ng/ml TGF-␤1 (Figure 4) , a concentration similar to that present in Matrigel or growth factor-reduced Matrigel ‫ف(‬ 2.3 and ‫ف‬ 1.7 ng/ml, respectively). Further, the priming effect of Matrigel was inhibited by a neutralizing antibody to TGF-␤1 ( Figure 5 ). Thus, TGF-␤1 is the major factor responsible for the priming effect of Matrigel on FcRI-dependent eicosanoid biosynthesis by BMMC.
Neither Matrigel nor TGF-␤1 affected secretory granule exocytosis of BMMC (Figures 2-5 ). This is consistent with the observation that TGF-␤1 did not affect the release of histamine from mouse peritoneal mast cells in response to the calcium ionophore A23187 (28, 29) and indicated that increased eicosanoid generation was not due to a general upregulation in signal transduction through FcRI. The increase in both prostanoid and LT generation and the increase in generation of proximal LT products (Figures 2C and 2D) suggested that matrix-associated TGF-␤1 primed BMMC for increased eicosanoid generation through upregulation of PLA 2 . BMMC from mice deficient in group IIA PLA 2 showed no impairment of eicosanoid generation (24), whereas eicosanoid generation was completely ablated in mice with disruption of the gene for cPLA 2 (26) . The upregulation of cPLA 2 in response to culture in Matrigel and the inhibition of this upregulation by an antibody to TGF-␤1 (Figures 6 and 7) are consistent with these observations. An increase in total LT biosynthesis might also be accounted for by increased expression of 5-LO/FLAP (17) . Matrigel elicited no consistent increase in expression of these proteins ( Figure 6 ) nor of COX-1, the first committed enzyme of immediate PGD 2 generation (15, 16) . We have previously reported that the upregulation of eicosanoid generation by BMMC in response to priming over 2 to 7 d with SCF was accompanied by increased expression of cPLA 2 (16) that was inhibited by IL-4 (30) and that was not accompanied by changes in expression of 5-LO. The effect of SCF was most marked on PGD 2 biosynthesis and also elicited an increase in expression of COX-1 (16) . In contrast, the IL-3-dependent increase in LTC 4 generation by BMMC was associated with increased expression of 5-LO and FLAP (17) . Thus, SCF, IL-3, and TGF-␤1 each elicit upregulation of eicosanoid generation by BMMC through different effects on the expression of eicosanoid biosynthetic enzymes.
TGF-␤1 is a versatile, 25-kD cytokine derived from cells of all hematopoietic lineages as well as cells of mesenchymal origin such as fibroblasts and endothelial cells (31, 32) . Latent TGF-␤1 is anchored to a fibrillin-like protein termed latent TGF-␤1 binding protein (LTBP) (31), presumably through interactions with type IV collagen and fibronectin (33) . Mast-cell chymase has been shown to mediate the cleavage of LTBP, releasing latent TGF-␤1 from extracellular matrix (34) . Treatment of BMMC derived in IL-3, SCF, and IL-9 with TGF-␤1 led to increased expression and release of the chymase mouse mast-cell protease 1 (35) . Although latent TGF-␤1 is not activated by mastcell chymase (34) it may be activated by type I, II, and III receptors for TGF-␤1 (31, 32) , expressed by mast cells (36) . Mast cells may also store and release TGF-␤1 upon activation (37) .
TGF-␤1 is pleotrophic in its effects on immune cells with both proinflammatory and anti-inflammatory actions whose effects are dependent on the context in which it acts (31, 32, 38, 39) . TGF-␤1 is chemotactic for mast cells (36) . It has been reported to inhibit the SCF-dependent induction of gelatinase B expression in a dog mastocytoma cell line (40) . TGF-␤1 inhibits proliferation of IL-3-and IL-4-dependent cultured mouse peritoneal mast cells and BALB/c BMMC grown in IL-3 (28) . Although TGF-␤1 inhibited the SCF rescue of BALB/c BMMC from apoptosis after IL-3 deprivation, it did not affect the viability and function of BALB/c BMMC grown in IL-3 (28, 29) . Our experiments confirmed that at concentrations up to 1 ng/ ml of TGF-␤1, viability of IL-3-dependent BMMC was not affected although proliferation was somewhat diminished (data not shown). These observations reveal a complex dynamic interaction between mast cells and TGF-␤1 in which mast cells may store, release, and activate TGF-␤1, which has pleotropic effects on mast-cell phenotype and function.
Murine mast cells originate from hematopoietic progenitors in the bone marrow, circulate as progenitors, and then reversibly change their phenotype in response to local microenvironments in peripheral tissues (6, 7) . Mast cells are exposed to basement membranes when they exit the circulation and when they aggregate beneath the epithelial surfaces of the skin, the respiratory system, the gastrointestinal and genitourinary tracts, and the connective tissue adjacent to blood or lymphatic vessels, providing an early defense to a variety of pathogens. Murine BMMC, activated by phorbol myristate acetate or SCF, and certain transformed mouse mast-cell lines, adhere to fibronectin (41, 42) , vitronectin (43) , and laminin (44, 45) . Thus, mast cells and their progenitors may interact with matrix-associated or basement membrane-associated TGF-␤1 during migration and maturation in peripheral tissues, inducing phenotypic changes and priming for eicosanoid biosynthesis. It is notable that several connective tissue disorders such as rheumatoid arthritis (46) , scleroderma (47), myelofibrosis (48, 49) and pulmonary fibrosis (50) demonstrate mast-cell hyperplasia in connection with increased levels of TGF-␤1 transcript and protein. Further, expression of TGF-␤1 is increased in the airways of asthmatic subjects (51, 52) , suggesting that it may contribute to the priming for increased LT generation observed in the asthmatic airways (53) . In conclusion, our data suggest that matrix-associated TGF-␤1 may not only recruit mast cells to sites of tissue inflammation but also substantially augment the capacity of mast cells to elicit or perpetuate an inflammatory response through provision of proinflammatory eicosanoids. 
